Catalyst Capital Advisors LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1549275
San Juan, PR
Position in TEVA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,231,908
-$1,131,882 QoQ
Shares Held
40,900
-61.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Catalyst Capital Advisors LLC holds $4,787,748 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
192,000 | $3,555,840 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
40,900 | $1,231,908 |
All Filings in TEVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,231,908 | 40,900 | Shares | Sole | 2026-05-06 | |
| 2024-12-31 | $2,363,790 | 107,250 | Shares | Other | 2025-01-31 | |
| 2024-09-30 | $2,019,141 | 112,050 | Shares | Other | 2024-10-30 | |
| No filing history on record for this holder in this stock. | ||||||